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Primary nephrotic syndrome in children: Clinical significance of
histopathologic variants of minimal change and of diffuse
mesangial hypercellularity
A REPORT OF THE INTERNATIONAL STUDY OF KIDNEY DISEASE IN CHILDREN
Studies published during the past two decades leave little
doubt that children with "minimal change" nephrotic syndrome
(MCNS) have a consistently good initial response to corticoste-
roid therapy and a good prognosis, whereas those with other
glomerular abnormalities have both a poorer initial response
and a poorer prognosis. About 95% of children with MCNS
respond to steroid therapy with a loss of proteinuria during S
weeks of intensive steroid therapy, and in about 98% protein-
uria disappears within 1 year. In contrast, the initial response
rate in patients with all other glomerular abnormalities is only
about 28% [1]. Renal biopsy is recommended, therefore, in
children who continue to have proteinuria after 8 weeks of
therapy, to identify patients with MCNS for whom a subse-
quent response can reasonably be expected and to exclude
other forms of glomerular abnormality [1].
The glomeruli in MCNS are customarily described as normal
by light microscopy. Electron microscopy usually shows only
epithelial changes with loss of foot processes. The histopatho-
logic concept of minimal glomerular change does, however,
include minor abnormalities, such as mild mesangial hypercel-
lularity, mild mesangial thickening, and focal glomerular obso-
lescence.
The present studies were carried out by the International
Study of Kidney Disease in Children (ISKDC) in a prospective
survey of a large number of children with primary nephrotic
syndrome, each of whom underwent a renal biopsy at the time
of diagnosis and before treatment was begun. The presence of
the histopathologic variability among patients with MCNS
prompted us, at the outset of the study in 1967, to identify five
histopathologic subgroups that could accommodate the small
alterations in glornerular morphology. We needed to make
provision also for biopsy samples showing varying degrees of
mesangial hypercellularity, which was classified, according to
its severity, as either mild (classified under MCNS as mild
mesangial hypercellularity) or severe (classified as diffuse pro-
liferative glomerulonephritis). It became evident that a category
intermediate between mild mesangial hypercellularity and dif-
fuse proliferative glomerulonephritis was needed, if only to
facilitate the identification of the small but morphologically
different group with moderate mesangial hypercellularity, des-
ignated as diffuse mesangial hypercellularity.
The purpose of this report is to describe histopathologic
changes seen in patients in the five subgroups of MCNS and in
patients with diffuse mesangial hypercellularity and to assess
their clinical significance.
Methods
Selection of patients. Between January 1967 and April 1976,
521 children with the nephrotic syndrome were admitted to the
study from 24 participating clinics. Patients had to satisfy the
following criteria: (I) heavy proteinuria  40 mg/hr/rn2 deter-
mined quantitatively on an overnight urine collection, (2) hy-
poalbuminemia  2.5 g/dl, (3) age  12 weeks and  16 years at
the time of diagnosis, (4) no prior treatment with steroids or
other cytotoxic immunosuppressive agents, and (5) no evidence
of underlying systemic disease or exposure to agents known to
be associated with the nephrotic syndrome.
Clinical methods. Established methods were used for data
collection, for coding and reporting, for clinical and laboratory
examination, and for standardization of age and sex-dependent
variables [2].
Histologic methods. The renal tissue was fixed in either
Duboscq-Brasil or 10% formalin solution, embedded in paraffin,
and cut by routine methods at each participating clinic. The
sections were stained with hematoxylin and eosin, periodic
acid-Schiff, periodic acid-silver methenarnine or Wilder reticu-
un, and Masson trichrome. The slides initially were examined
by the four consulting pathologists individually and then by all
four pathologists together to arrive at a concensus on the
classification of each biopsy into one of five arbitrarily defined
histopathologic subgroups of MCNS or into the category of
diffuse mesangial hypercellularity. Finally, the histologic
changes were quantified in counts of the total number of
glomeruli and the number of sclerotic glomeruli, and in esti-
mates, on an arbitrary scale of 0 to 3+ (none, mild, moderate,
severe) denoting the degrees of mesangial hypercellularity,
mesangial thickening, and focal tubular changes.
Definitions
Prednisone regimens. Initial treatment was 60 mg/24 hr/rn2
(maximum dosage 80 mg/24 hr) in divided doses for 4 weeks,
followed by 40 mg/24 hr/rn2 in divided doses, 3 consecutive days
out of 7 for4 weeks. Treatment of relapse was 60 mg/24 hr/rn2 in
divided doses until response (maximum of 4 weeks), followed
by 40 mg/24 hr/m2 in divided doses, 3 consecutive days ow: of 7
for 4 weeks.
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Fig. 1. Examples f glomeruli illustrating different de-
grees of mesangial hypercellularity a nil disease. The
mesangium contains few cells and is not expanded; the
glomerulus is normal in respect to the degree of mesangial
cellularity. b Mild ,nesangial hypercellularily. The mesan-
gium contains clusters of nuclei so that the total cellularity
is mildly increased; the mesangium may be expanded in
areas of increased cellularity by slight increases in matrix.
c Diffuse mesangial hypercellularitv. The mesangial cells
are diffusely increased in number, and the mesangium is
expanded by both increased cells and increased matrix.
(All sections stained with PAS; magnification, x300).
Fig. 2.One of three glomeruli that has undergone collapse
and obsolescence (focal glo,nerular obsolescence); the
other two gloineruli have no increase in mesangial cd/u-
Ian! v. (PAS stain; magnification. x300).
Clinical definitions. Response was denoted by a reduction in
rate of urinary excretion of protein to < 4mg/hr/rn2 (Albustix C
to trace) for 3 consecutive days. Relapse was denoted by a
reappearance of proteinuria 40 mg/hr/rn2 (Albustix + + or
greater) for 3 consecutive days. Initial responder was any
patient who responded during the 8 weeks of initial prednisone
regimen. Early relapser was any initial responder who relapsed
during the 8 weeks of the initial prednisone regimen. Frequent
relapser was any initial responder who had 2 or more relapses
within 6 months of the initial response. Initial nonresponder
was any patient who failed to respond during the initial 8 weeks
of prednisone therapy. Late responder was any initial nonre-
sponder who responded at some time after treatment with the
initial 8 weeks of prednisone regimen. Late nonresponder was
any initial responder who subsequently failed to respond.
Histopathologic definitions. The term MCNS was used when
glomeruli were histologically normal or only slightly modified
[3]. The presence of occasional glomerular obsolescence unac-
companied by tubular atrophy did not remove a specimen from
this category, but segmental sclerosis was excluded. The
glomerular capillary walls were normal and the lumens patent.
MCNS was divided into the following five categories: (1) Nil
disease. Glomeruli were entirely normal by light microscopy
with neither mesangial thickening nor mesangial hypercellular-
ity. There was neither glomerular obsolescence nor tubular
abnormality (Fig. Ia). (2) Focal glomerular obsolescence. Focal
global glomerular sclerosis was present unaccompanied by
tubular atrophy (Fig. 2). Although there was theoretically no
limit to the number of completely sclerotic or obsolete glomeru-
ii, a proportion in excess of 10% was usually accompanied by
tubular atrophy, which put the biopsy in a diagnostic category
other than mimal change. (3) Mild mesangial thickening. Slight
increases in the amount of PAS-positive mesangial matrix were
present without increased cellularity. (4) Focal tubular
changes. There were (a) tubular atrophy unaccompanied by
glomerular sclerosis, (b) tubular dilatation with epithelial flat-
tening, or (c) tubular casts. The last were often calcified,
partially extruded through the tubular walls, and encased in
proliferated epithelium or mononuclear cells. Both tubular
atrophy and calcified casts were usually accompanied by adja-
cent interstitial fibrosis (Fig. 3). (5) Mild tnesangial hypercellu-
larity. There was a mild increase of mesangial nuclei, only
slightly exceeding the normal number, either segmental or
diffuse, with normal capillary walls and patent lumens (Fig. lb).
The classification diffuse mesangial hypercellularity indicates
a diffuse increase in mesangial nuclei, usually accompanied by a
diffuse increase in mesangial matrix, but unaccompanied by
segmental glomerular sclerosis (Fig. Ic). The increase in cellu-
larity exceeded that seen in mild mesangial hypercellularity and
could be characterized as moderate.
Evaluation of glomerular hypercellularity included allow-
ances for variation in the thickness of sections, and cellularity
was judged in the peripheral portions of the glomerular stalk.
The differentiation between mild and diffuse mesangial hyper-
cellularity was based on subjective evaluation of the number of
cells in the glomerular stalks.'
When more than one of these abnormalities were present in a
single biopsy, the histopathologic category assigned for pur-
poses of clinicopathologic correlation followed these priorities:
'The visual impression of mildly or moderately increased cellularity
used as the basis of classification in this study has since been codified
by the WHO Committee on Classification and Nomenclature of Renal
Disease on the basis of the number of cells per peripheral mesangial
area [41. In the WHO classification, one or two cells per peripheral
mesangial area are accepted as normal, whereas three cells are indica-
tive of mild mesangial hypercellularity. Four or more cells are regarded
as mesangial glomerulonephritis in the WHO classification, correspond-
ing to diffuse mesangial proliferation in this study. Mild mesangial
hypercellularity is differentiated, therefore, from nil disease on the one
hand and from diffuse mesangial hypercellularity on the other. The
difference, although clear in concept, may be difficult in practice, even
though the pathologists involved in this study achieved a high degree of
consistency in making the necessary distinctions. More precise, mor-
phometric methods might effect a clearer separation of these variations,
but the techniques are too laborious for routine use. Morphometric
studies of MCNS have in general shown significantly increased mesan-
gial cellularity [5, 6].
International Study of Kidney Disease in Children 767
I
•£
-4-• - :U
a.:
-' -'
I,
-
.
Nt
'r' ' -'
.11.
&•: -
-_• .-
a
- ,_'s>s-
N .
-S
¶ 4,\
__a
.•
_.,a4. •;;
a -%$- -I • .-z—:
"e #
' _a •. -
-: —- —• •
-. ae( a
a - —-S' -
- a -
t -.e—--
S
Fig. 3. Examples qf tubular abnormalities characterized
as focal tubular changes: a Tubules in a cluster contain
faintly PAS-positive casts and are lined with flattened
epithelium; these casts in formalin-fixed tissue can usually
be demonstrated to contain calcium. b Tubules (arrows)
contain lightly PAS-positive, calcified casts that are par-
tially extruded from the tubular lumens and are surround-
ed by proliferated cells. (Both sections stained with PAS;
magnification, >< 300).
(1) diffuse mesangial hypercellularity, (2)mild mesangial hyper-
cellularity, (3) focal tubular changes, (4) mild mesangial thick-
ening, (5) focal glomerular obsolescence, and (6) nil disease.
The histopathologic evaluations and diagnoses were made
without knowledge of clinical characteristics at the onset or of
the subsequent course of disease.
The following definitions apply to the distribution of lesions:
(1) global, a lesion affecting the whole of the glomerulus; (2)
segmental, a lesion affecting only a part of the glomerulus, the
remainder being normal; (3) focal, a lesion affecting <80% of
glomeruli in the specimen; (4) d(Ifuse, a lesion affecting  80%
of the glomeruli in the specimen.
Statistical analyses. Comparisons between patients in each
of the six groups were tested statistically using ax2 contingency
table with five degrees of freedom (N-I). Although it would
have been desirable to be able to use a level of significance of
<0.05, a more conservative level of < 0.01 was used in these
analyses because of the small expected frequencies in several
categories. Where statistical significance was found, a 2-x-2
contingency table was used to establish the level of significance
of differences between particular subgroups, and P values were
calculated using five degrees of freedom (N-I) instead of 1. In
these analyses, P values < 0,05 were considered significant
because the expected frequencies exceeded five.
Results
The 521 children with the nephrotic syndrome included 389
with MCNS,2 of whom 219 had nil disease, 98 had focal
glomerular obsolescence, 16 had mild mesangial thickening, 29
had focal tubular changes, and 27 had mild mesangial hypercel-
lularity. There were 12 patients with diffuse mesangial hypercel-
lularity. Complete urinary data required for the analyses in this
report were available for 372 patients at 8 weeks, 358 at 6
months, 343 at 1 year, and 301 at 2 years.
Data on the clinical and laboratory characteristics at the time
of diagnosis of patients with MCNS among the 521 patients with
2The small differences between the number of patients with MCNS in
this report and the numbers in references 1 and 2 resulted from
reclassification of some patients.
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Time after starting treatment
(a'eeks) n
8 (initial nonreponders) 10
16 4
26 3
52 2
104 2
the primary nephrotic syndrome have been reported previously
[2]. Data from the present analysis on these characteristics in
patients in the six groups are shown in Table 1. No statistically
significant differences were observed except for age. The
difference in the proportions of patients  6 years of age among
the six groups (P < 0.001) was due to a larger proportion of
patients with focal glomerular obsolescence 6 years than in
the other five groups (P — 0.03).
The number of days between onset of treatment and time of
response (mean 13.3, median 11, and range 3 to 48) in all initial
responders and the number of days between initial response and
time of first relapse (mean 116, median 86, and range 3 to 616) in
patients who relapsed during 2 years from the time of the first
response were not different among the six groups.
As shown in Table 2, there were, however, significant
differences in the proportions of initial nonresponders among
patients in the six groups (P < 0.001). The percentages of initial
nonresponders among patients with focal tubular changes
(14.3), mild mesangial hypercellularity (14.8), and diffuse me-
sangial hypercellularity (45.5) as a group were significantly
higher (P < 0.02) than the group with nil disease (4.7), focal
glomerular obsolescence (7.8), and mild mesangial thickening
(6.3). The proportion of initial nonresponders in patients with
diffuse mesangial hypercellularity was significantly higher (P <
n
5 45.5
3 27.3
2 18.2
1 9.1
9.1
0.05) than it was in those with mild mesangial hypercellularity.
Proteinuria subsided at some point in 23 (74.2%) of the total of
31 initial nonresponders, and by 52 weeks the differences in the
proportions of the remaining few with persistent proteinuria
were no longer statistically significant.
There were no significant differences among the groups in the
proportions of initial responders who became early relapsers.
frequent relapsers, or late nonresponders (Table 3). There also
were no significant differences among the groups in the propor-
tions of patients who died. A similar analysis of the subsequent
course in initial nonresponders in the six groups would not be
meaningful because the numbers in some categories were so
small and because the majority of them were entered into
therapeutic trials early in their course and treated in a variety of
ways [7, 8].
Discussion
The higher proportion of initial nonresponders among pa-
tients with focal tubular changes and mild or diffuse mesangial
hypercellularity suggests that these patients differ clinically as
well as histopathologically from those with nil disease, focal
glomerular obsolescence, and mild mesangial thickening. The
long-term clinical importance of this observation cannot be
assessed at present. Proteinuria subsided at some point in three-
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Table 1. Proportions of patients in each histopathologic category with clinical or laboratory characteristics used generally to differentiate among
forms of glomerular disease associated with the nephrotic syndrome in childrena
Histopathologic categories
Nil FGO MMT FTC MMH DMH
Characteristics n/N % n/N n/N 9/ n/N n/N n/N 9/
Age  6 yr 172/219 78.5 90/98 9! 8b 12/16 75.0 17/29 58.6 19/27 70.4 9/12 75.0
Sex: female 79/219 36.! 31/98 31.6 6/16 37.5 11/29 37.9 8/27 29.6 4/12 33.3
Diastolic BP > 98 percentile 25/195 12.8 11/82 13.4 1/14 7.1 6/25 24.0 5/24 20.8 I/Il 9.1
Hematuria > 100,000 RBC/hr/m2 43/191 22.5 16/90 17.8 3/12 25.0 6/27 22.2 9/25 36.0 4/9 44.4
SerumC3 <9Omg/dI 2/16! 1.2 3/62 4.8 0/lI 0.0 0/18 0.0 0/2! 0.0 0/8 0.0
Selectivity index > 0.2 20/122 16.4 5/48 10.4 0/9 0.0 2/12 16.7 5/16 31.3 1/4 25.0
Serum crcatinine > 98 percentile 43/179 24.0 30/81 37.0 7/13 53.8 6/25 24.0 6/21 28.6 6/Il 54.5
a Abbreviations used are Nil, nil disease: FGO, focal glomerular obsolescence: MMT, mild mesangial thickening: FTC, focal tubular changes;
MMH, mild mesangial hypercellularity; DMH, diffuse mesangial hypercellularity; N. number of patients in each category with data on each
characteristic; n, number of patients with that characteristic.
b FGO vs. others P < 0.03.
Table 2. Percentages of patients in each histopathologic category with persistent proteinuria at time in weeks after starting initial treatment with
prednisone'
Histopathologic categories
Nil
(N = 2ll) FGO(N = 90) MMT(N = 16) FTC(N = 28) MMH(N —27) DMH(N = II)
(4 n c/r n (4 V/ ii
4.7
1.9
1.4
0.9
0.9
7
4
3
2
2
7.8
4.4
3.3
2.2
2.2
1
I
I
0
0
6.3
6.3
6.3
0.0
0.0
4
3
3
I
0
14.3
10.7
10.7
3.6
0.0
4
4
4
2
2
14.8
14.8
14.8
7.4
7.4
a Abbreviations used are Nil, nil disease: FGO, focal glomerular obsolescence: MMT. mild mesangial thickening; FTC, focal tubular changes;
MMH, mild mesangial hypercellularity; DMH, diffuse mesangial hypercellularity: N, number of patients in each category with data on response; n,
number of patients with persistent proteinuria.
b Thisnumber includes II patients with Nil who responded within 8 weeks but did not have complete urinary data for the entire 8-week period.
Nil
FGO
MMT
FTC
MMH
DMH
quarters of the 31 initial nonresponders, and by 52 weeks there
were no longer any statistically significant differences among
the six groups. There also were no statistically significant
differences in the proportion of initial responders among the six
groups who were early or frequent relapsers or late nonre-
sponders. These findings suggest that a slower disappearance of
proteinuria initially may not be associated with a difference in
the subsequent clinical course.
Among the patients with MCNS being followed by the
ISKDC, the percentage of initial nonresponders dying during
the first 2 years was significantly higher than it was among
initial responders (International Study of Kidney Disease in
Children, to be published), The death rates in patients with
focal tubular changes and mild or diffuse mesangial hypercellu-
larity were not significantly higher than they were in the other
groups of patients, although failure to detect differences could
be due to the small number of patients in each group. If, in
addition to higher proportions of initial nonresponders in pa-
tients with focal tubular changes, mild mesangial hypercellular-
ity, and diffuse mesangial hypercellularity, it should turn out
that the death rate or another aspect of their later course
indicates a more serious disease, the clinical significance of
these histopathologic groups would require reassessment. The
categories in this study have been established on the basis of
light microscopic evaluation. Perhaps the inclusion of immuno-
fluorescence and electron microscopy would have resulted in
the identification of different categories or in different criteria.
But, except for the occurrence of mesangial 1gM (discussed
below), such studies have not altered the histologic subclassifi-
cation of minimal change nephrotic syndrome.
The meaning of the findings in patients with focal tubular
changes is not known. Some of the biopsy samples in this
category were identified on the basis of focal tubular atrophy
unaccompanied by glomerular sclerosis; conceivably, our rec-
ognition of accompanying glomerular sclerosis was impaired by
limited sampling. The majority of biopsy samples identified as
focal tubular changes contained foci of tubular damage with
calcified casts, a finding of unknown etiology and importance.
Previous investigations concerning the clinical significance of
mild degrees of mesangial hypercellularity have led to contra-
dictory results: the lesion has been associated both with a good
response to steroid therapy [9, 10] and with a less than
favorable response [Ill. Some of the contradictory results
relate almost certainly to differences in histopathologic criteria.
Our results show that, in comparison with nil disease, a higher
proportion of patients with mild mesangial hypercellularity are
initial nonresponders. More severe degrees of mesangial hyper-
cellularity, seen in patients with diffuse mesangial hypercetlu-
larity, were associated with an even poorer initial response to
steroids, as reported by others [12, 131. But, the association
between degree of hypercellularity and disappearance of pro-
teinuria was no longer apparent at 52 weeks, suggesting that the
interval between beginning steroid treatment and assessing the
response may account for some of the contradictory results
reported.
Several explanations can be offered for the reduced initial
steroid responsiveness that accompanies increased mesangial
cellularity. In an earlier report of the JSKDC on patients with
the primary nephrotic syndrome [I], it was found that approxi-
mately one quarter of nonresponders at 8 weeks had MCNS.
These nonresponders constituted, however, only 6.9% of pa-
tients with MCNS. In contrast, initial nonresponders with mild
or diffuse mesangial hypercellularity constituted, respectively,
14.8 and 45.5% of patients. These higher percentages of initial
nonresponders might suggest that mesangial hypercellularity in
patients in whom no other glomerular lesions are found is
indicative of underlying focal segmental glomerulosclerosis,
which is known to be associated with mesangial hypercellular-
ity and in which we found the initial nonresponse rate to be
70.3% [1]. But the disappearance of proteinuria at some point
before 52 weeks in 35 of the 38 patients with mild or diffuse
mesangial hypercellularity would tend not to support the con-
tention that focal segmental glomeruloscierosis was over-
looked.
A second explanation is that mesangial hypercellularity rep-
resents a reaction to primary immune complex injury and is a
form of chronic glomerulonephritis. This seems unlikely for two
reasons. Despite the high proportion of initial nonresponders,
almost all of these patients became free of proteinuria at some
point during the first year. In addition, except for the occasional
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Table 3. Proportions of initial responders in each histopathologic category who were early relapsers, frequent relapsers, or late nonresponders,
and proportion of all patients who dieda
Early relapsers Frequent relapsers Late nonresponders Deaths
Fl/Nh n/Nc n/Na % n/Ne
34/191 17.8 82/185 44.3 27/178 15.2 4/219 1.8
15/83 18.1 26/77 33.8 7/71 9.9 2/98 2.0
3/IS 20.0 2/14 14.3 2/13 15.4 1/16 6.3
6/24 25.0 10/24 41.7 4/23 17.4 2/29 6.9
4/23 17.4 6/22 27.3 2/22 9.1 1/27 3.7
2/6 33.3 0/5 0.0 1/4 25.0 0/12 0.0
Total 64/342 18.7 126/327 38.5 43/311 13.8 10/401 2.5
a Abbreviations used are Nil, nil disease; FGO, focal glomerular obsolescence; MMT, mild mesangial thickening; FTC, focal tubular changes;
MMH, mild mesangial hypercellularity; DMH, diffuse mesangial hypercellularity; N, number of patients in each category with sufficient data to
determine clinical course; n, number of patients who were early relapsers, frequent relapsers, or late nonresponders, or who died.b Initial responders with daily urinary data for 8 weeks
Initial responders with daily urinary data for 6 months from time of 1st response
' Initial responders with daily urinary data for 12 months from time of 1st response
All patients
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occurrence of 1gM [14, 15], which could reflect nonspecific
trapping as a result of impaired mesangial clearance of macro-
molecules, it has been general experience that glomerular
deposits of immunoglobulins are not found in patients with
mesangial hypercellularity unaccompanied by other glomerular
lesions.
A third explanation, which we favor, is that mesangial
hypercellularity reflects nonimmunologic injury to the mesan-
gium resulting in mesangial dysfunction. Our finding that the
degree of hyperceltularity correlates with the rate at which
proteinuria subsides suggests that mesangial hypercellularity
reflects a spectrum of glomerular injury among patients classi-
fied histopathologically as nil disease, mild mesangial hypercel-
lularity, and diffuse mesangial hypercellularity.
The results presented here should affect the judgment of
ultimate prognosis in a nonresponder at 8 weeks, who, on
biopsy, is found to have mild or diffuse mesangial hypercellular-
ity. But, the proportions of these patients in whom proteinuria
disappeared and the favorable subsequent course in most of
them, at least during the first 2 years, would not justify their
being given drugs with potentially greater toxicity than predni-
sone.
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